Venetoclax plus azacitidine and LDAC induced high response rates in acute myeloid leukaemia in routine clinical practice.
Yi LiuLi ZhuZuopo LvLiping MaoChao HuJinghan WangYile ZhouJie JinHaitao MengLiang-Shun YouPublished in: British journal of haematology (2023)